PubMed ID:
22339929
Public Release Type:
Journal
Publication Year: 2012
Affiliation: Mayo Clinic, Rochester, MN 55905, USA.
DOI:
https://doi.org/10.1111/j.1365-2982.2012.01894.x
Authors:
Abell T,
Abell TL,
Atkinson M,
Baxter L,
Belt P,
Bernard C,
Bernard CE,
Bishop R,
Calles J,
Calles J,
Culler S,
DeVole N,
Donithan M,
Farrugia G,
Farrugia G,
Faussone-Pellegrini MS,
Fordham J,
Greene M,
Green M,
Grover M,
Grover M,
Hamilton F,
Hamilton FA,
Harbison S,
Hasler W,
Hasler WL,
Hejazi R,
Henry O,
Hooker J,
Isaacson M,
James S,
Kantor S,
Kedar A,
Kendrick M,
Koch K,
Koch KL,
Lee L,
Lee L,
Louiseau S,
Lurken M,
Lurken MS,
Lytes V,
May KP,
McCallum RW,
McCallum RW,
McNair V,
Miriel L,
Nguyen L,
Nguyen L,
NIDDK Gastroparesis Clinical Research Consortium (GpCRC),
Palit A,
Parker S,
Parkman HP,
Parkman HP,
Pasricha PJ,
Pasricha PJ,
Pillor E,
Ponsetto C,
Sachdeva P,
Sarosiek I,
Sarr M,
Shen K,
Shetler K,
Simmons K,
Smyrk TC,
Snape W,
Snape WJ,
Spree D,
Stuart P,
Tonascia J,
Tonascia J,
Torrance R,
Ullah N,
Ünalp-Arida A,
Ünalp-Arida A,
Van Natta M,
Van Raaphorst R,
Vasquez D,
Vaughn I,
Vega N,
Wilson L,
Yates K
Studies:
Gastroparesis Clinical Research Consortium
,
Nortriptyline for Idiopathic Gastroparesis
Cellular changes associated with diabetic (DG) and idiopathic gastroparesis (IG) have recently been described from patients enrolled in the Gastroparesis Clinical Research Consortium. The association of these cellular changes with gastroparesis symptoms and gastric emptying is unknown. The aim of this study was to relate cellular changes to symptoms and gastric emptying in patients with gastroparesis.